| Up-down regulation of HIF-1α in cancer progression M Rashid, LR Zadeh, B Baradaran, O Molavi, Z Ghesmati, M Sabzichi, ... Gene 798, 145796, 2021 | 214 | 2021 |
| Laccase: Various types and applications SH Khatami, O Vakili, A Movahedpour, Z Ghesmati, H Ghasemi, ... Biotechnology and Applied Biochemistry 69 (6), 2658-2672, 2022 | 124 | 2022 |
| β‐Galactosidase: From its source and applications to its recombinant form A Movahedpour, N Ahmadi, F Ghalamfarsa, Z Ghesmati, M Khalifeh, ... Biotechnology and Applied Biochemistry 69 (2), 612-628, 2022 | 61 | 2022 |
| An update on the secretory functions of brown, white, and beige adipose tissue: Towards therapeutic applications Z Ghesmati, M Rashid, S Fayezi, F Gieseler, E Alizadeh, M Darabi Reviews in Endocrine and Metabolic Disorders 25 (2), 279-308, 2024 | 35 | 2024 |
| Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses NH Goradel, A Alizadeh, S Hosseinzadeh, M Taghipour, Z Ghesmati, ... Future Oncology 18 (2), 245-259, 2022 | 30 | 2022 |
| Designing a humanized immunotoxin based on DELTA-stichotoxin-Hmg2a toxin: an in silico study Z Ghesmati, S Mokhtari, M Parvanak, HR Siahkouhi, M Taheri-Anganeh, ... Journal of Molecular Modeling 28 (12), 392, 2022 | 1 | 2022 |
| Targeting hypoxia-inducible factor 1 alpha augments synergistic effects of chemo/immunotherapy via modulating tumor microenvironment in a breast cancer mouse model M Rashid, M Ramezani, O Molavi, Z Ghesmati, B Baradaran, M Sabzichi, ... | | 2025 |
